Informa Australia is part of the Informa Connect Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Defence & Security
Defence is entering a new paradigm, preparing to engage with industry on the fourth generation of lucrative contracts for Estate and Base Services. As Minister for Defence Industry Melissa Price recently told Australian Defence Magazine (ADM), the department is getting ready to start engaging industry on future long-term contracts worth about $1.2 billion a year. “Defence wants to…
30 Sep 2021, by Skye RytenskildHealthcare
There's a new, glimmering frontier in healthcare. Artificial Intelligence (AI) and Machine Learning are reshaping the future, with the potential to relieve the burden on health professionals and allow physicians to connect better with patients. Also known as ‘Deep Medicine’, AI and Machine Learning can help cut down the cost of healthcare. From transforming note taking and…
28 Sep 2021, by Skye RytenskildHealthcare
Empowering Australians with the tools they need to take control of their own health is an impetus sweeping across the nation's health sector. Around 40% of Australians now live with chronic health conditions and half of all hospital admissions are related. There’s clearly an urgent need for meaningful change to the way chronic disease is…
15 Sep 2021, by Skye RytenskildInfrastructure
Mining & Resources
Transport & Logistics
The sweeping Gascoyne region of Western Australia is vast in its potential. Spanning over 137,000 square kilometres, it boasts more than 600 km of Indian Ocean coastline, stretching more than 500km inland through to the remote outback. It is also the door to the neighbouring Pilbara and Midwest regions. A new development wants to unlock…
8 Sep 2021, by Skye RytenskildHealthcare
One of the upsides of the pandemic is that it has shown that Australia has a remarkable ability to respond when swift action is needed in drug development. However, while we're known as a leading destination for early phase clinical trials, there has been a historic disconnect with wider commercialisation and bringing our solutions to…
6 Sep 2021, by Skye Rytenskild